RT null
T1 Mitral valve in valve: A new choice to be still cautious
A1 Ferrera, Carlos
A1 Almería, Carlos
A1 Maroto Castellanos, Luis Carlos
A1 Cobiella, Javier
A1 De Agustín Loeches, José Alberto
A1 Rodrigo López, José Luis
A1 Islas, Fabián
A1 Marcos-Alberca, Pedro
A1 Rodríguez, José Enrique
A1 Pérez De Isla, Leopoldo
A1 Macaya Miguel, Carlos
AB As the aging population grows, there is a parallel increase of degenerative valvulopathies. In the same way, bioprosthesis implanted years ago may undergo a gradual deterioration over time. Increased risk of reoperation is well known, but today it is the unique option for degenerated bioprosthesis. This situation leads to a crossover of two main issues: on the one side, an increase in aged-patient proportion, and on the other side, the higher risk from reoperation.
PB Elsevier
SN 1874-1754
YR 2014
FD 2014
LK https://hdl.handle.net/20.500.14352/131366
UL https://hdl.handle.net/20.500.14352/131366
LA eng
NO Ferrera, C., Almería, C., Maroto, L., Cobiella, J., de Agustín, J. A., Rodrigo, J. L., Islas, F., Marcos-Alberca, P., Rodríguez, J. E., Pérez de Isla, L., & Macaya, C. (2014). Mitral valve in valve: a new choice to be still cautious. International journal of cardiology, 171(2), 304–307. https://doi.org/10.1016/j.ijcard.2013.11.070
DS Docta Complutense
RD 25 feb 2026